Watch & wait
Clinical trials for Watch & wait explained in plain language.
Never miss a new study
Get alerted when new Watch & wait trials appear
Sign up with your email to follow new studies for Watch & wait, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug delay the need for lymphoma treatment?
Disease control Not yet recruitingThis phase 2 trial compares two approaches for people with untreated, low-tumor-burden follicular lymphoma: receiving the investigational drug epcoritamab or being closely monitored without treatment. The goal is to see if epcoritamab can extend the time before standard treatment…
Matched conditions: WATCH & WAIT
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Liver cancer breakthrough? study tests surgery vs. drug maintenance after successful initial therapy
Disease control Not yet recruitingThis study looks at 100 liver cancer patients whose tumors shrank or disappeared after initial therapy. It compares two follow-up options: surgery to remove any remaining cancer, or continuing medication (maintenance therapy). The goal is to see which approach better prevents the…
Matched conditions: WATCH & WAIT
Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC